Gurion, R., Rozovski, U., Itchaki, G., Gafter-Gvili, A., Leibovitch, C., Raanani, P., Ben-Zvi, H., Szwarcwort, M., Taylor-Abigadol, M., Dann, E. J., Horesh, N., Inbar, T., Tzoran, I., Lavi, N., Fineman, R., Ringelstein-Harlev, S. and Horowitz, N. A. (2022) “Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies”, Haematologica. Pavia, Italy, 107(3), pp. 715-720. doi: 10.3324/haematol.2021.279216.